Thomas Andersen

  • Stavanger University Hospital

My Publications

Podocan is not associated with increased risk in chest pain patients.

  • Frontiers in Cardiovascular Medicine
  • May 2022

New inflammation blood test (cxcl16) predicts death, heart attack and stroke

  • Arteriosclerosis Thrombosis and Vascular Biology
  • September 2019

Inflammatory blood test Pentraxin 3 predicts death, new heart attack and stroke after a...

  • European Heart Journal Acute Cardiovascular Care
  • April 2019

CXC MOTIF LIGAND 16: A NOVEL, INDEPENDENT PREDICTOR OF CARDIOVASCULAR DEATH AND MORBIDI...

  • Journal of the American College of Cardiology
  • March 2019